isospaglumic acid has been researched along with Huntington Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casseb, RF; Castellano, G; Cendes, F; D'Abreu, A; Lopes-Cendes, I; Ruocco, HH | 1 |
| Carter, RE; Coyle, JT; Passani, LA; Vonsattel, JP | 1 |
| Coyle, JT; Passani, LA; Vonsattel, JP | 1 |
3 other study(ies) available for isospaglumic acid and Huntington Disease
| Article | Year |
|---|---|
Thalamic metabolic abnormalities in patients with Huntington's disease measured by magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Case-Control Studies; Creatine; Deuterium; Dipeptides; Female; Glycerylphosphorylcholine; Humans; Huntington Disease; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Activity; Phosphocreatine; Phosphorylcholine; Thalamic Diseases; Thalamus; Trinucleotide Repeats; Young Adult | 2013 |
N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases.
Topics: Alzheimer Disease; Amino Acids; Antigens, Surface; Aspartic Acid; Brain; Case-Control Studies; Cell Count; Dipeptidases; Dipeptides; Glutamate Carboxypeptidase II; Humans; Huntington Disease; Neurons; Neuropeptides; Reference Values | 1997 |
Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antibody Specificity; Antigen-Antibody Reactions; Brain Chemistry; Brain Mapping; Brain Stem; Case-Control Studies; Cerebral Cortex; Dipeptides; Female; Humans; Huntington Disease; Male; Middle Aged; Neuropeptides; Reference Values; Spinal Cord | 1997 |